CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-75
SponsorPontificia Universidad Catolica de Chile
About this trial
The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery.
The participants will:
* Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump. * Be monitored via telephone by the research team to complete the QoR-15 survey, assess pain levels, the need for tramadol use, and any complications. * Have follow-up by the Acute Pain Unit during the first 3 days.
Eligibility criteria
Qualifiers
Adults (≥18 years, < 75 years) scheduled for elective outpatient arthroscopic rotator cuff repair surgery.
Patients capable of managing a continuous outpatient regional analgesia system based on an interscalene block (eligibility criteria: able to understand verbal and written instructions, have home support, and live geographically close to the healthcare center).
Willing and able to provide informed, written consent to participate in the study.
Disqualifiers
History of chronic opioid use (>3 months).
Severe comorbidities (e.g., renal or hepatic failure, ASA classification of 3 or higher).
Allergy to local anesthetics, dexamethasone, or the analgesic drugs used in the study.
Patients with contraindications for peripheral nerve block.
Trial design
Treatments tested in this trial
- Continuous perineural infusion
- Single injection
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov